{"pmid":32499225,"title":"Pathologists and the coronavirus distraction effect.","text":["Pathologists and the coronavirus distraction effect.","J Clin Pathol","Troncone, Giancarlo","Hofman, Paul","32499225"],"journal":"J Clin Pathol","authors":["Troncone, Giancarlo","Hofman, Paul"],"date":"2020-06-06T11:00:00Z","year":2020,"_id":"32499225","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1136/jclinpath-2020-206807","keywords":["lung neoplasms","molecular biology","pathology, molecular"],"topics":["Prevention"],"weight":1,"_version_":1668804508777447424,"score":9.490897,"similar":[{"pmid":32201224,"pmcid":"PMC7174827","title":"Managing COVID-19 in the oncology clinic and avoiding the distraction effect.","text":["Managing COVID-19 in the oncology clinic and avoiding the distraction effect.","Ann Oncol","Cortiula, F","Pettke, A","Bartoletti, M","Puglisi, F","Helleday, T","32201224"],"journal":"Ann Oncol","authors":["Cortiula, F","Pettke, A","Bartoletti, M","Puglisi, F","Helleday, T"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32201224","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.annonc.2020.03.286","topics":["Prevention"],"weight":1,"_version_":1666138492413935618,"score":63.80902},{"pmid":32434770,"title":"Predictive molecular pathology in the time of COVID-19.","text":["Predictive molecular pathology in the time of COVID-19.","AIMS: In the time of COVID-19, predictive molecular pathology laboratories must still timely select oncological patients for targeted treatments. However, the need to respect social distancing measures may delay results generated by laboratory-developed tests based on sequential steps a long hands-on time. Laboratory workflows should now be simplified. METHODS: The organisation of the University of Naples Federico II predictive pathology laboratory was assessed before (March-April 2019) and during (March-April 2020) the Italian lockdown. RESULTS: The number of patients undergoing single or multiple biomarker testing was similar in 2019 (n=43) and in 2020 (n=45). Considering adequate samples for molecular testing, before the outbreak, next-generation sequencing was mostly used (35/42, 83.3%). Testing six genes had a reagent cost of euro98/patient. Conversely, in 2020, almost all cases (38/41, 92.7%) were analysed by automated testing. This latter had for any single assay/gene a significant reagent cost (euro95-euro136) and a faster mean turnaround time (5.3 vs 7.9 working days). CONCLUSION: In the times of coronavirus, laboratory fully automated platforms simplify predictive molecular testing. Laboratory staff may be more safely and cost-effectively managed.","J Clin Pathol","Malapelle, Umberto","De Luca, Caterina","Iaccarino, Antonino","Pepe, Francesco","Pisapia, Pasquale","Russo, Maria","Sgariglia, Roberta","Nacchio, Mariantonia","Vigliar, Elena","Bellevicine, Claudio","Schmitt, Fernando C","Troncone, Giancarlo","32434770"],"abstract":["AIMS: In the time of COVID-19, predictive molecular pathology laboratories must still timely select oncological patients for targeted treatments. However, the need to respect social distancing measures may delay results generated by laboratory-developed tests based on sequential steps a long hands-on time. Laboratory workflows should now be simplified. METHODS: The organisation of the University of Naples Federico II predictive pathology laboratory was assessed before (March-April 2019) and during (March-April 2020) the Italian lockdown. RESULTS: The number of patients undergoing single or multiple biomarker testing was similar in 2019 (n=43) and in 2020 (n=45). Considering adequate samples for molecular testing, before the outbreak, next-generation sequencing was mostly used (35/42, 83.3%). Testing six genes had a reagent cost of euro98/patient. Conversely, in 2020, almost all cases (38/41, 92.7%) were analysed by automated testing. This latter had for any single assay/gene a significant reagent cost (euro95-euro136) and a faster mean turnaround time (5.3 vs 7.9 working days). CONCLUSION: In the times of coronavirus, laboratory fully automated platforms simplify predictive molecular testing. Laboratory staff may be more safely and cost-effectively managed."],"journal":"J Clin Pathol","authors":["Malapelle, Umberto","De Luca, Caterina","Iaccarino, Antonino","Pepe, Francesco","Pisapia, Pasquale","Russo, Maria","Sgariglia, Roberta","Nacchio, Mariantonia","Vigliar, Elena","Bellevicine, Claudio","Schmitt, Fernando C","Troncone, Giancarlo"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32434770","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1136/jclinpath-2020-206711","keywords":["laboratory personnel","medical oncology","pathology, molecular"],"locations":["Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1667521393637457923,"score":61.881435},{"pmid":32366599,"title":"SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma.","text":["SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, pathologists can be exposed to infection handling surgical specimens. Guidelines related to safety procedures in the laboratory have been released. However, there is a lack of studies performed on biopsy and surgical resection specimens. Here we report the detection of SARS-CoV-2 in formalin-fixed paraffin-embedded samples from surgical resection of tongue squamous cell carcinoma of a patient who developed COVID-19 postsurgery. RNA of SARS-CoV-2 strain was detected in the tumour and the normal submandibular gland samples using real-time PCR-based assay. No viral RNA was found in metastatic and reactive lymph nodes. We demonstrated that SARS-CoV-2 RNA can be detected in routine histopathological samples even before COVID-19 disease development. These findings may give important information on the possible sites of infection or virus reservoir, and highlight the necessity of proper handling and fixation before sample processing.","J Clin Pathol","Guerini-Rocco, Elena","Taormina, Sergio Vincenzo","Vacirca, Davide","Ranghiero, Alberto","Rappa, Alessandra","Fumagalli, Caterina","Maffini, Fausto","Rampinelli, Cristiano","Galetta, Domenico","Tagliabue, Marta","Ansarin, Mohssen","Barberis, Massimo","32366599"],"abstract":["In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, pathologists can be exposed to infection handling surgical specimens. Guidelines related to safety procedures in the laboratory have been released. However, there is a lack of studies performed on biopsy and surgical resection specimens. Here we report the detection of SARS-CoV-2 in formalin-fixed paraffin-embedded samples from surgical resection of tongue squamous cell carcinoma of a patient who developed COVID-19 postsurgery. RNA of SARS-CoV-2 strain was detected in the tumour and the normal submandibular gland samples using real-time PCR-based assay. No viral RNA was found in metastatic and reactive lymph nodes. We demonstrated that SARS-CoV-2 RNA can be detected in routine histopathological samples even before COVID-19 disease development. These findings may give important information on the possible sites of infection or virus reservoir, and highlight the necessity of proper handling and fixation before sample processing."],"journal":"J Clin Pathol","authors":["Guerini-Rocco, Elena","Taormina, Sergio Vincenzo","Vacirca, Davide","Ranghiero, Alberto","Rappa, Alessandra","Fumagalli, Caterina","Maffini, Fausto","Rampinelli, Cristiano","Galetta, Domenico","Tagliabue, Marta","Ansarin, Mohssen","Barberis, Massimo"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366599","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1136/jclinpath-2020-206635","keywords":["pathology, molecular","pathology, oral","viruses"],"e_drugs":["Formaldehyde","Paraffin"],"topics":["Diagnosis"],"weight":1,"_version_":1666138496183566337,"score":58.962513},{"pmid":32494076,"title":"Bolstering Africa's coronavirus detection efforts.","text":["Bolstering Africa's coronavirus detection efforts.","Nature","Tsanni, Abdullahi","32494076"],"journal":"Nature","authors":["Tsanni, Abdullahi"],"date":"2020-06-05T11:00:00Z","year":2020,"_id":"32494076","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1038/d41586-020-01607-y","keywords":["careers","infection","molecular biology"],"locations":["Bolstering Africa's"],"topics":["General Info"],"weight":1,"_version_":1668712823965876224,"score":56.180088},{"pmid":32316712,"title":"[Explore the Optimal Resolvent of Medical Needs and Mental Health for Patients with Lung Cancer during Epidemic Novel Coronavirus Pneumonia].","text":["[Explore the Optimal Resolvent of Medical Needs and Mental Health for Patients with Lung Cancer during Epidemic Novel Coronavirus Pneumonia].","BACKGROUND: With the rapid spread of novel coronavirus pneumonia (NCP) worldwide and the escalation of prevention and control efforts, the routine medical needs of patients have been restricted. The aims were to investigate medical needs of lung cancer patients and their mental health status during the epidemic periods, so as to provide rational recommendations for subsequent diagnosis and treatment. METHODS: The questionnaire was sent in the form of an electronic questionnaire at 7am on 4th, March, 2020, until 7am 6th, March, 2020, 368 questionnaires were recollected from 25 provinces (autonomous regions/municipalities) in 48 h. RESULTS: Of the 368 patients, 18 patients were excluded as they didn't receive anti-tumor treatment, and 350 patients were included in the final analysis. 229 cases were treated with oral targeted drugs, and 121 cases were treated with chemotherapy or immunotherapy. 41.3% of patients treated with intravenous chemotherapy or immunotherapy experienced treatment discontinuation, and the proportion of treatment discontinuation in chemotherapy or immunotherapy was higher than those treated with oral targeted drugs (21.0%). Whether oral targeted drugs or intravenous chemotherapy or immunotherapy, more than 60% of patients experienced delays in imaging examinations. Nearly one third of patients developed new symptoms or exacerbation of existing symptoms. 26.6%-28.9% of patients have changed their treatment plans through online consultation. During novel coronavirus pneumonia, 40%-75% of lung cancer patients have mental health problems, and more than 95% of patients support government's prevention and control measures. CONCLUSIONS: During the emergence of NCP, the medical needs of patients with lung cancer have not been enough, especially those who discontinued chemotherapy or immunotherapy. When medical institution resumes work, priority should be given to them. At the same time, mental health problems of patients should be valued and resolved timely.","Zhongguo Fei Ai Za Zhi","Xu, Haiyan","Yang, Ke","Yang, Guangjian","Yang, Lu","Mi, Yuling","Cui, Xiaohong","Yang, Min","Wang, Dan","Wang, Yan","32316712"],"abstract":["BACKGROUND: With the rapid spread of novel coronavirus pneumonia (NCP) worldwide and the escalation of prevention and control efforts, the routine medical needs of patients have been restricted. The aims were to investigate medical needs of lung cancer patients and their mental health status during the epidemic periods, so as to provide rational recommendations for subsequent diagnosis and treatment. METHODS: The questionnaire was sent in the form of an electronic questionnaire at 7am on 4th, March, 2020, until 7am 6th, March, 2020, 368 questionnaires were recollected from 25 provinces (autonomous regions/municipalities) in 48 h. RESULTS: Of the 368 patients, 18 patients were excluded as they didn't receive anti-tumor treatment, and 350 patients were included in the final analysis. 229 cases were treated with oral targeted drugs, and 121 cases were treated with chemotherapy or immunotherapy. 41.3% of patients treated with intravenous chemotherapy or immunotherapy experienced treatment discontinuation, and the proportion of treatment discontinuation in chemotherapy or immunotherapy was higher than those treated with oral targeted drugs (21.0%). Whether oral targeted drugs or intravenous chemotherapy or immunotherapy, more than 60% of patients experienced delays in imaging examinations. Nearly one third of patients developed new symptoms or exacerbation of existing symptoms. 26.6%-28.9% of patients have changed their treatment plans through online consultation. During novel coronavirus pneumonia, 40%-75% of lung cancer patients have mental health problems, and more than 95% of patients support government's prevention and control measures. CONCLUSIONS: During the emergence of NCP, the medical needs of patients with lung cancer have not been enough, especially those who discontinued chemotherapy or immunotherapy. When medical institution resumes work, priority should be given to them. At the same time, mental health problems of patients should be valued and resolved timely."],"journal":"Zhongguo Fei Ai Za Zhi","authors":["Xu, Haiyan","Yang, Ke","Yang, Guangjian","Yang, Lu","Mi, Yuling","Cui, Xiaohong","Yang, Min","Wang, Dan","Wang, Yan"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32316712","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3779/j.issn.1009-3419.2020.101.18","keywords":["lung neoplasms","mental health","novel coronavirus pneumonia"],"topics":["Prevention"],"weight":1,"_version_":1666138493708926976,"score":54.234375}]}